Tower Research Capital »

Terns Pharmaceuticals shares owned by Tower Research Capital

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.1k 619 6.56
2023-09-30 $5.3k 1.1k 5.06
2023-06-30 $70k 8.0k 8.75
2023-03-31 $43k 3.7k 11.80
2022-12-31 $57k 5.5k 10.32
2022-09-30 $39k 6.6k 5.91
2022-06-30 $26k 11k 2.46
2022-03-31 $11k 3.6k 3.09
2021-12-31 $11k 1.5k 7.13
2021-09-30 $8.0k 759 10.54
2021-06-30 $13k 1.2k 10.64
2021-03-31 $14k 614 22.80